David Peace

3.8k total citations
79 papers, 2.1k citations indexed

About

David Peace is a scholar working on Oncology, Hematology and Immunology. According to data from OpenAlex, David Peace has authored 79 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 29 papers in Hematology and 26 papers in Immunology. Recurrent topics in David Peace's work include Hematopoietic Stem Cell Transplantation (21 papers), Immunotherapy and Immune Responses (19 papers) and Acute Myeloid Leukemia Research (14 papers). David Peace is often cited by papers focused on Hematopoietic Stem Cell Transplantation (21 papers), Immunotherapy and Immune Responses (19 papers) and Acute Myeloid Leukemia Research (14 papers). David Peace collaborates with scholars based in United States, China and Philippines. David Peace's co-authors include Martin A. Cheever, W Chen, Shu-Han You, Jeffrey A. Sosman, Damiano Rondelli, D E Kern, Koen van Besien, Heidi Nelson, John G. Quigley and P D Greenberg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Nature Communications.

In The Last Decade

David Peace

78 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Peace United States 27 864 767 650 422 396 79 2.1k
Andrew L. Gilman United States 25 817 0.9× 750 1.0× 648 1.0× 771 1.8× 260 0.7× 60 2.8k
John P. Greer United States 31 772 0.9× 1.3k 1.7× 914 1.4× 386 0.9× 556 1.4× 119 3.3k
Elizabeth Naparstek Israel 28 705 0.8× 571 0.7× 1.3k 1.9× 335 0.8× 412 1.0× 98 2.3k
Clay Smith United States 21 625 0.7× 541 0.7× 1.1k 1.6× 611 1.4× 533 1.3× 51 2.2k
Krzysztof Warzocha Poland 26 857 1.0× 672 0.9× 614 0.9× 518 1.2× 999 2.5× 169 2.6k
Belinda R. Avalos United States 23 709 0.8× 779 1.0× 1.0k 1.6× 387 0.9× 227 0.6× 100 2.1k
LL Sensenbrenner United States 24 525 0.6× 500 0.7× 1.2k 1.9× 376 0.9× 426 1.1× 67 2.0k
Samantha Jaglowski United States 24 896 1.0× 940 1.2× 992 1.5× 466 1.1× 1.5k 3.7× 152 2.9k
Brian T. Hill United States 27 475 0.5× 1.2k 1.5× 482 0.7× 746 1.8× 790 2.0× 225 2.7k
Nicola Cascavilla Italy 27 530 0.6× 517 0.7× 1.1k 1.7× 510 1.2× 758 1.9× 114 2.1k

Countries citing papers authored by David Peace

Since Specialization
Citations

This map shows the geographic impact of David Peace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Peace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Peace more than expected).

Fields of papers citing papers by David Peace

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Peace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Peace. The network helps show where David Peace may publish in the future.

Co-authorship network of co-authors of David Peace

This figure shows the co-authorship network connecting the top 25 collaborators of David Peace. A scholar is included among the top collaborators of David Peace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Peace. David Peace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zakharia, Yousef, Eric A. Singer, Rohan Garje, et al.. (2024). Durvalumab and guadecitabine in advanced clear cell renal cell carcinoma: results from the phase Ib/II study BTCRC-GU16-043. Nature Communications. 15(1). 972–972. 6 indexed citations
2.
Atkins, Michael B., Opeyemi A. Jegede, Naomi B. Haas, et al.. (2023). Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B). Journal for ImmunoTherapy of Cancer. 11(3). e004780–e004780. 19 indexed citations
3.
Saraf, Santosh L., Annie Oh, Pritesh Patel, et al.. (2018). Haploidentical Peripheral Blood Stem Cell Transplantation Demonstrates Stable Engraftment in Adults with Sickle Cell Disease. Biology of Blood and Marrow Transplantation. 24(8). 1759–1765. 43 indexed citations
4.
Saba, Raya, et al.. (2016). Long-term survival consequent on the abscopal effect in a patient with multiple myeloma. BMJ Case Reports. 2016. bcr2016215237–bcr2016215237. 10 indexed citations
5.
Nutescu, Edith A., Julio D. Duarte, Wendy Cheng, et al.. (2014). Abstract 16119: Novel Genotype Guided Personalized Warfarin Service Improves Outcomes in an Ethnically Diverse Population. Circulation. 130. 6 indexed citations
6.
Rosenbaum, Cara A., David Peace, Elizabeth Rich, & Koen van Besien. (2008). Granulocyte Colony-Stimulating Factor-Based Stem Cell Mobilization in Patients with Sickle Cell Disease. Biology of Blood and Marrow Transplantation. 14(6). 719–723. 15 indexed citations
7.
8.
Margolin, Kim, Koen van Besien, & David Peace. (2007). An Introduction to Foundation and Industry-Sponsored Research: Practical and Ethical Considerations. Hematology. 2007(1). 498–503. 3 indexed citations
9.
Saraf, Santosh L., Nadim Mahmud, David Peace, et al.. (2006). Prolonged responses after autologous stem cell transplantation in African-American patients with multiple myeloma. Bone Marrow Transplantation. 37(12). 1099–1102. 14 indexed citations
10.
Hallmeyer, Sigrun, Nadim Mahmud, Linda R. Bressler, et al.. (2005). Induction of specific T cell immunity in patients with prostate cancer by vaccination with PSA146–154 peptide. Cancer Immunology Immunotherapy. 55(9). 1033–1042. 47 indexed citations
11.
Srivastava, Richa, et al.. (2005). Distinct cytokine patterns exist in peripheral blood mononuclear cell cultures of patients with prostate cancer. Clinical Immunology. 117(1). 94–99. 9 indexed citations
12.
Medin, Jeffrey A., et al.. (2005). Efficient transfer of PSA and PSMA cDNAs into DCs generates antibody and T cell antitumor responses in vivo. Cancer Gene Therapy. 12(6). 540–551. 24 indexed citations
13.
Besien, Koen van, Steven M. Devine, Amittha Wickrema, et al.. (2003). Safety and outcome after fludarabine–thiotepa–TBI conditioning for allogeneic transplantation: a prospective study of 30 patients with hematologic malignancies. Bone Marrow Transplantation. 32(1). 9–13. 7 indexed citations
14.
Verma, Anita, Steven M. Devine, Mary Morrow, et al.. (2003). Low incidence of CMV viremia and disease after allogeneic peripheral blood stem cell transplantation. Role of pretransplant ganciclovir and post-transplant acyclovir. Bone Marrow Transplantation. 31(9). 813–816. 15 indexed citations
15.
Sosman, Jeffrey A., et al.. (2002). Induction of Tc2 cells with specificity for prostate-specific antigen from patients with hormone-refractory prostate cancer. Cancer Immunology Immunotherapy. 51(5). 263–270. 18 indexed citations
16.
Sanborn, Rachel E., Wendy Stock, David Peace, et al.. (2001). Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplant. Bone Marrow Transplantation. 28(6). 557–562. 26 indexed citations
17.
18.
Peace, David, Jerry W. Smith, W Chen, et al.. (1994). Lysis of ras oncogene-transformed cells by specific cytotoxic T lymphocytes elicited by primary in vitro immunization with mutated ras peptide.. The Journal of Experimental Medicine. 179(2). 473–479. 57 indexed citations
19.
Peace, David, Joseph Wayne Smith, Mary L. Disis, Wei Chen, & Martin A. Cheever. (1993). Induction of T Cells Specific for the Mutated Segment of Oncogenic P21ras Protein by Immunization In Vivo with the Oncogenic Protein. Journal of Immunotherapy. 14(2). 110–114. 13 indexed citations
20.
Cheever, Martin A., Wei Chen, Mary L. Disis, Masazumi Takahashi, & David Peace. (1993). T‐Cell Immunity to Oncogenic Proteins Including Mutated RAS and Chimeric BCR‐ABLa. Annals of the New York Academy of Sciences. 690(1). 101–112. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew L. Gilman Breakdown of academic impact, for papers by John P. Greer Breakdown of academic impact, for papers by Elizabeth Naparstek Breakdown of academic impact, for papers by Clay Smith Breakdown of academic impact, for papers by Krzysztof Warzocha Breakdown of academic impact, for papers by Belinda R. Avalos Breakdown of academic impact, for papers by LL Sensenbrenner Breakdown of academic impact, for papers by Samantha Jaglowski Breakdown of academic impact, for papers by Brian T. Hill Breakdown of academic impact, for papers by Nicola Cascavilla
Rankless by CCL
2026